Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib may help regrow hair in alopecia areata patients.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.